Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05093699 · ClinicalTrials.gov registry record · NA
Dual-plane Ultrasound Imaging During Vascular Access Procedures
A NA study of Vascular Access Complication, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT05093699: Completed NA study of Vascular Access Complication, sponsored by Mayo Clinic.
NCT05093699 is a NA study of Vascular Access Complication that has completed, run by Mayo Clinic. The registered enrollment target is 98 participants, below the 740-participant average among 6 other Vascular Access Complication trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05093699, a NA study of Vascular Access Complication, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are evaluating the clinical efficiency of utilization of a dual-plane simultaneous view ultrasound probe (Butterfly iQ+; Butterfly Network, Inc.) during arterial catheter placement in the operating room
Primary Outcome
Number of first-stick success rate of ultrasound-guided peripheral arterial catheter placement
Conditions Studied
Interventions
- DEVICE Butterfly iQ+ ultrasound probe
- DEVICE Ultrasound probe
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
What the finished NCT05093699 record still lists
NCT05093699 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 740-participant average among 6 other Vascular Access Complication trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Vascular Access Complication appearing as the primary indexed condition, and to 2 interventions - of which Butterfly iQ+ ultrasound probe is the first listed.
NCT05093699 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05093699 about?
NCT05093699 is a clinical study titled "Dual-plane Ultrasound Imaging During Vascular Access Procedures". Researchers are evaluating the clinical efficiency of utilization of a dual-plane simultaneous view ultrasound probe (Butterfly iQ+; Butterfly Network, Inc.) during arterial catheter placement in the operating room
What is the current status of trial NCT05093699?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2022-05-01. Estimated completion is 2024-03-01.
What conditions does trial NCT05093699 study?
This clinical trial studies the following conditions: Vascular Access Complication.
What interventions are being tested in trial NCT05093699?
The interventions under investigation include: Butterfly iQ+ ultrasound probe (DEVICE), Ultrasound probe (DEVICE).
Who is sponsoring clinical trial NCT05093699?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05093699 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Access Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Access Cannulation Trial II
RECRUITING · NA
-
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
RECRUITING · NA
-
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
ACTIVE NOT RECRUITING · Phase 1
-
RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial
COMPLETED · Phase 3
-
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI